Delivery Order SPE2DB22D3301-SPE2DB25FY9RX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100 count) with a ceiling value of $5,774.04. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 8, 2025. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,706.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 10 mg capsules (100 count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the DLA. This award is issued...
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,760.99 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count). The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.50 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, with no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be performed and delivered from the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) with a contract ceiling value of $2,727.39. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,442.92 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $1.82K to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (100-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,125.58 and has an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp will perform this contract from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9RXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,573.66 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100-count units) on August 19, 2025, with completion targeted for August 20, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical (contract number SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The parent contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and SAM-registered vendor, AmerisourceBergen has demonstrated consistent capability to fulfill federal procurement requirements through competitive awards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/19/25 |